Infliximab Selectively Modulates the Circulating Blood Monocyte Repertoire in Crohn's Disease

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Inflammatory Bowel Diseases

• Publication date

  2016-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MIB.0000000000000964PMID 27824651
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of peripheral classical and non-classical monocytes on infliximab treatment in patients with rheumatoid arthritis and ankylosing spondylitis

  2016cited by this paper
• New Insights into the Mechanisms of Action of Anti–Tumor Necrosis Factor-&agr; Monoclonal Antibodies in Inflammatory Bowel Disease

  2015cited by this paper
• Intestinal permeability – a new target for disease prevention and therapy

  2014cited by this paper
• The monocyte-macrophage axis in the intestine

  2014cited by this paper
• CD14hiHLA‐DRdim macrophages, with a resemblance to classical blood monocytes, dominate inflamed mucosa in Crohnˈs disease

  2014cited by this paper
• Infliximab therapy increases the frequency of circulating CD16+ monocytes and modifies macrophage cytokine response to bacterial infection

  2014cited by this paper
• Regulatory macrophages induced by infliximab are involved in healing in vivo and in vitro

  2012cited by this paper
• Crohn's disease

  2012cited by this paper
• Intestinal macrophages and response to microbial encroachment

  2011cited by this paper
• Anti-tumor necrosis factor-α antibodies induce regulatory macrophages in an Fc region-dependent manner.

  2011cited by this paper
• Reporter gene assay for the quantification of the activity and neutralizing antibody response to TNFα antagonists.

  2011cited by this paper
• Subclinical Intestinal Inflammation in Siblings of Children with Crohn’s Disease

  2010cited by this paper
• Transmembrane TNF-α: structure, function and interaction with anti-TNF agents

  2010cited by this paper
• Nomenclature of monocytes and dendritic cells in blood.

  2010cited by this paper
• Standardized single‐platform assay for human monocyte subpopulations: Lower CD14+CD16++ monocytes in females

  2010cited by this paper
• Investigating the role of proinflammatory CD16+ monocytes in the pathogenesis of inflammatory bowel disease

  2010cited by this paper
• Non‐response to infliximab may be due to innate neutralizing anti‐tumour necrosis factor‐α antibodies

  2008cited by this paper
• Monocytes and their pathophysiological role in Crohn’s disease

  2008cited by this paper
• Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis.

  2008cited by this paper
• Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor alpha-expressing cells: comparison among infliximab, etanercept, and adalimumab.

  2008cited by this paper
• Mouse models of inflammatory bowel disease.

  2007cited by this paper
• Mechanism of action of certolizumab pegol (CDP870): In vitro comparison with other anti‐tumor necrosis factor &agr; agents

  2007cited by this paper
• Increased subpopulations of CD16+ and CD56+ blood monocytes in patients with active Crohn's disease

  2007cited by this paper
• Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis

  2006cited by this paper
• Dual regulation of soluble tumor necrosis factor-alpha induced activation of human monocytic cells via modulating transmembrane TNF-alpha-mediated 'reverse signaling'.

  2006cited by this paper
• Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities

  2006cited by this paper
• IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction.

  2006cited by this paper
• Dual regulation of soluble tumor necrosis factor-α induced activation of human monocytic cells via modulating transmembrane TNF-α-mediated ‘reverse signaling’

  2006cited by this paper
• Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha.

  2005cited by this paper
• Adalimumab induces apoptosis of human monocytes: a comparative study with infliximab and etanercept

  2005cited by this paper
• Effect of different tumor necrosis factor (TNF) reactive agents on reverse signaling of membrane integrated TNF in monocytes.

  2004cited by this paper
• Infliximab maintenance therapy for fistulizing Crohn's disease.

  2004cited by this paper
• Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.

  2004cited by this paper
• Proinflammatory Cytokines Disrupt Epithelial Barrier Function by Apoptosis-Independent Mechanisms 1

  2003cited by this paper
• Subclinical intestinal inflammation: an inherited abnormality in Crohn's disease relatives?

  2003cited by this paper
• Effects of Infliximab on Apoptosis and Reverse Signaling of Monocytes from Healthy Individuals and Patients with Crohn’s Disease

  2003cited by this paper
• The CD16+ (FcγRIII+) Subset of Human Monocytes Preferentially Becomes Migratory Dendritic Cells in a Model Tissue Setting

  2002cited by this paper
• Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.

  2002cited by this paper
• Binding and functional comparisons of two types of tumor necrosis factor antagonists.

  2002cited by this paper
• Tumour necrosis factor in mouse models of chronic intestinal inflammation

  2002cited by this paper
• CD16+ and CD16- human blood monocyte subsets differentiate in vitro to dendritic cells with different abilities to stimulate CD4+ T cells.

  2001cited by this paper
• Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway.

  2001cited by this paper
• Reverse Signaling Through Transmembrane TNF Confers Resistance to Lipopolysaccharide in Human Monocytes and Macrophages1

  2000cited by this paper
• Infliximab for the treatment of fistulas in patients with Crohn's disease.

  1999cited by this paper
• Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

  1999cited by this paper
• Selective depletion of CD14+ CD16+ monocytes by glucocorticoid therapy

  1998cited by this paper
• Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa

  1995cited by this paper
• Transforming growth factor-beta in synovial fluids modulates Fc gamma RII (CD16) expression on mononuclear phagocytes.

  1992cited by this paper
• A simple index of Crohn's-disease activity.

  1980cited by this paper
• [Crohn's disease].

  1967cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper

• Initial or continuous coculture with umbilical cord-derived mesenchymal stromal cells facilitates in vitro expansion of human regulatory T-cell subpopulations

  2025cites this paper
• Exhaustion profile on classical monocytes after LPS stimulation on Crohn's disease patients.

  2025cites this paper
• The Roles of Monocytes and Macrophages in Behçet’s Disease With Focus on M1 and M2 Polarization

  2022cites this paper
• Targeting Immune Cell Metabolism in the Treatment of Inflammatory Bowel Disease

  2021cites this paper
• Biological Treatments in Inflammatory Bowel Disease: A Complex Mix of Mechanisms and Actions

  2021cites this paper
• Human Monocyte Subset Distinctions and Function: Insights From Gene Expression Analysis

  2020cites this paper
• CyBorD-DARA is potent initial induction for MM and enhances ADCP: initial results of the 16-BCNI-001/CTRIAL-IE 16-02 study.

  2019cites this paper
• Phenotypic and functional heterogeneity of human intermediate monocytes based on HLA-DR expression

  2019cites this paper
• Efecto modulador ex vivo de los fármacos biológicospara la enfermedad inflamatoria intestinal sobre lascélulas mononucleares de sangre periférica y lamucosa intestinal

  2019cites this paper
• Chronic Kidney Disease Severity Is Associated With Selective Expansion of a Distinctive Intermediate Monocyte Subpopulation

  2018cites this paper
• Phenotypic and functional heterogeneity of human intermediate monocytes based on HLA‐DR expression

  2018cites this paper
• Regulation of Innate and Adaptive Immunity by TGFβ.

  2017cites this paper